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pattern in stress myocardial scintigraphy (1â€”7).Therefore,
stress-rest @Tc-teboroxime imaging could offer some ad
vantages over 2O1'i@early redistribution in differentiating
between reversible and fixed defects (6, 7). On the other
hand, some features of @â€œ@Tc-teboroximekinetics, mainly
the strict relation of its uptake to coronary blood flow and
the very high first-pass extraction (4,8â€”10),could unfavor
ably affect the capability of severely hypoperfused but
viable myocardium to take up a sufficient amount of the
tracer to be effectively visualized. Preliminary experiences
comparing rest @Â°â€˜Tc-teboroximeimaging with 201'flrein
jection showed the superiority of the latter in detecting
perfusion defect reversibility (11 ). Theoretically, a tran
sient improvement of rest coronary blood flow before
@Tc-teboroximeinjection could increase uptake by the
severely hypoperfused territories. The acute administra
tion of nitrates was reported to improve the regional myo
cardial blood flow at rest (12) and during exercise (13).
Furthermore, sublingual nitroglycerin was shown to in
crease the reversibility of perfusion defects following 201'fl
reinjection (14â€”16).This preliminary study aimed to test
the hypothesis that the uptake of @Tc-teboroximein ex
ercise-induced perfusion defects could be improved by re
peating the rest injection of the tracer after the administra
tion of ISDN.
METhODS
Patient Population and Study Protocol
The study group was recruited from patients referred to our
Nuclear Medicine laboratory for 201'flexercise myocardial scm
tigraphy. The following inclusion criteria had to be fulfilled: his
tot)' of proven prior myocardial infarction dating back no more
than 2 yr and no less than 1 mo; suspected effort angina and/or
ischemic electrocardiographic changes during exercise stress test
ing; absence of heart disease other than coronary arteiy disease;
and willingness to participate in the study after having given
informed consent. For all patients the results of a recently per
formed coronary angiography were available or its execution had
already been planned independently of the radionuclide investi
gations. The final study group consisted of ten patients, all male,
mean age 56.1 Â±6.7 yr. Study protocol required the withdrawal of
nitrates at least 48 hr before beginning the radionuclide examina
tions. Exercise 201'fland @Tc-teboroximemyocardial scintigra
Previous studies demonstrate perfusion defect reversibility in
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phy were performedin random sequence and within 5 days of
each other. The protocol was approved by the ethics committee of
our institution.
Thallium-201 Myocardial Scintigraphy
After overnight fasting, the patients underwent a symptom
limited exercise in upright position using a bicycle ergometer,
starting with a 30 W work load, which was increased by 30 W
every 3 mm. Thallium-201 (74 MBq) was injected at peak effort
and the patientkept exercisingfora further60sec. Earlyand4-hr
redistribution scans were collected. After redistribution imaging,
55MBqof2O1i@werereinjectedatrest,followedbyimageacqui
sition 30 mm later (17). Three-view (best septal and steep left
anterior oblique and anterior) planar studies were collected using
either a Siemens Rotacamera or an Elscint Apex SP4 camera,
equipped with a low-energy all-purpose parallel hole collimator,
using two 20% energy windows centered at the 70 and 167 keV
photopeaksof20â€•fl.Theacquisitiontimewas400secperview for
each study, using a zoom factor and a 128 x 128computer matrix.
Techn@um-99m-Teboroxlme Myocardial Scintigraphy
Ona separateday, exercisestress testingwasperformedin the
same manner and at peak exercise 555 MBq of @â€œTc-teboroxime
were injected. After injection the exercise was continued for an
additional 30 sec and imaging was started immediately using the
same gamma camera, collimator, zoom factor and computer ma
trix of the 201@flstudy for each patient. A 20% energy window
centered at the 140 keV photopeak of @â€œ@Tcwas employed. The
same three planar views of the 2oâ€•flstudy were acquired, begin
fling with the steep left anterior oblique projection, followed by
the best septal left anterior oblique and by the anterior view.
Acquisition time was 60 sec each for the first two views and 120
sec for the last one. Image collection was always completed within
7 mm of tracer injection. Approximately one hr later an equal
tracer amount was injected at rest and the baseline images were
collected using the same procedure. Forty mm after rest imaging
sublingual ISDN (5 mg) was given. A dose of 555 MBq of @â€œ@Tc
teboroxime was then injected as soon as a 10 mmHg systolic
blood pressure drop was measured and a new set of rest images
was immediatelycollectedusingthe abovedescribedprocedure.
Image Evaluation
Both 20â€•fland @Tc-teboroximestudies were evaluated in
random order, blindly and independently by two experienced
observers.Disagreementsweresolvedby consensuswiththe help
of a third reviewer. Analog images on x-ray film and digital com
puter displays were used. No smoothing or background subtrac
tion was performed. Each scan was divided into seven segments
(three segments/view, with the apical segment common to all
three views) (18). Tracer uptake was visually graded using the
following scoring scheme: 0 = normal; 1 = slightly, but clearly
reduced uptake; 2 = moderately reduced; 3 = severely reduced
and 4 = absent uptake. The score of the abnormal segments in
each scan was summed up to give the total defect score. Each
abnormal segment in the stress images was then evaluated for
defect reversibility by comparing its score with that of the related
redistribution or reinjection 2o1'flscans and, respectively, @â€œTc
teboroxime rest or ISDN images. Those segments with unchanged
or higher scores were classifiedas fixed and those with score
decrease were classified as reversible.
Statistical AnalysIs
All data are expressed as the mean Â±s.d. Continuous variables
were compared using the Student's t-test for paired data. The total
defect scores obtained in the various scans were compared using
the Wilcoxon ranks test for paired data. The defect classification
obtained by the two tracers using the different imaging protocols
was compared using the McNemar chi square test for related
proportions. A p value <0.05 was considered significant.
RESULTS
Patient Population
Eight patients showed electrocardiographic signs of pre
vious anterior and two of previous inferior myocardial in
faction. None of the patients had symptoms or signs of left
ventricular dysfunction. A wall motion abnormality (either
hypokinesia or akinesia) was demonstrated in all infarcted
territories using contrast ventriculography, however, the
left ventricular ejection fraction was >50% in all patients.
Using a 50% vessel lumen narrowing as the angiographic
threshold for the diagnosis of signfficant coronary artery
disease, three patients were found to be affected by one
vessel, two by two-vessel and five by three-vessel disease
during coronary angiography.
During the two stress tests, similar durations (@Â°1Tl
!0.5 Â±2.9 min versus @Tc-teboroxime !0.3 Â±2.7, ns)
and double product values (@Â°â€˜Tl2!679 Â±3992 bpm x
mmHg versus @Tc-teboroxime 22937 Â±3355, ns) were
achieved, and the same end point was reached in each
patient.
Myocardial PerfusIon ImagIng
Exercise 20111images showed a mean of !90K counts
over the myocardium, redistribution images a mean of
140K counts, and reinjection images a mean of 175K
counts. The image quality of the @â€œ@Tc-teboroximestudi s
was poorer, with a mean of 50K counts over the myocar
dium on exercise scan. This increased to 75K counts in rest
and to lOOKcounts in ISDN images. Furthermore, a high
liver activity was found in the @â€˜@Tc-teboroximeimages.
Although this was reported to impair the evaluation of the
inferior wall (18), particularly in the steep left anterior
oblique view, by collecting this projection first, the assess
ment of the inferior wall uptake score was performed in all
patients without problems. Disagreements in scoring were
rare: 29 in a total of 420 assigned scores (6.9%) never
exceeding 1 score unit. Figure 1 shows a typical example of
the images obtained in our study. The scintigraphic results
of the patient population are summarized in Table 1 and in
Figure 2.
All patients had abnormal 201'flexercise scans and the
total defect score/patient was 10.5 Â±3.1. In the redistribu
tion images the total defect score decreased to 7.4 Â±2.7
(p < 0.02 versus exercise). After reinjection, a further
decrease to 4.8 Â±2.! (p < 0.0! versus both exercise and
redistribution) was observed. Of the 44 abnormal segments
in the 201'flstress images, 26 were classffied as reversible
and 18 as fixed when compared with the redistribution
scan. After reinjection, the uptake score improved in 24
segments and the final classification was 37 reversible and
7 fixed defects (p < 0.005 versus redistribution).
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20111
Patient
no. EX RED REINJ@9c-teboroximeEX REST ISDN
EX= exercise;RED= redlstribution;REINJ= reinjection;ISDN= restimagingafterISDN.Foreachsetof images,thetotaldefectscoreand
thenumberof abnormalsegments(inparentheses)is reported.
The overall agreement between 201'fland @Tc-teborox
ime stress images in detecting perfusion defects was good
(p = 0.37). More specifically, a disagreement was observed
only in five of 70 segments: @â€˜@Tc-teboroximeuptake was
normal in one segment with a 201'flgrade 2 defect and was
abnormal (grade 1) in four segments with normal @Â°â€˜Tl
uptake.
The total defect score/patient in the @â€œ@Tc-teboroxime
exercise images was 12.7 Â±3.1 (p < 0.05 versus
exercise). In the rest images this value decreased to 7.3 Â±
3.3 (p < 0.01versusexercise,NS versus201'flredistribu
tion). After ISDN, the total defect score was 5.6 Â±2.6 (p <
0.02 versus rest, p < 0.05 versus 201'flredistribution, NS
versus 201T1reinjection). Of the 47 segments with a perfu
sion defect in the exercise images, 34 were classffied as
reversible and 13 as fixed by the rest @Tc-teboroxime
images. In the @â€œ@Tc-teboroximestudy after ISDN, the
uptake score was found to be improved in 20 segments.
Thus, 39 were classffied as reversible and 8 as fixed (ns
versus rest).
For a better direct comparison of @Tc-teboroximewith
20111data concerning defect reversibility, the analysis was
restricted to the 44 segments with an abnormal @Â°â€˜Tlexer
cise scan. Of these, 33 were classified as reversible and!!
as fixed by the sequence of stress and rest @Tc-teborox
ime images (NS versus both @Â°â€˜Tlredistribution and rein
jection). In the rest @Tc-teboroxime images obtained by
reinjecting the tracer after ISDN, however, the classifica
tion of 4 segments, all included in the patients' infarcted
territories, was changed from fixed to reversible. There
fore, the same ultimate result was obtained as that in 201'fl
reinjection (37 reversible and 7 fixed segments, NS) and a
significant difference was achieved compared to @Â°@Tlre
distribution (p < 0.01).
DISCUSSION
Early redistribution images with 201@flare known to un
derestimate the reversibility of stress-induced perfusion
:@
FIGURE 1. Best septal leftanteriorplanarviewofa patientw@i
three-vesseldiseaseand pre@ousmyocard@infarction.Thallium
201 images on the leftand digital @Tc-teboroximeimages on the
right Aclear-cutdefectoftheseptalandapicalwallisdetectedinthe
exercisescans (upperrow); which is significantlyreducedin the
20111 redistribution and @rc-teborodme rest images (middle row),
and has almost disappearedin the @@111reinjectionand @Fc
teboroximeimagesafter ISDN(lowerrow).
TABLEI
Scintigraphicfindings in the patient population
15 (4)3 (3)3 (3)1 1(4)5 (4)3(3)210
(4)10 (4)7 (4)12 (4)10(4)8(4)39
(3)5 (3)2 (2)1 1(3)3 (3)1(1)41
1(4)9 (4)5 (4)12 (4)7(4)6(4)58
(4)8 (4)4 (3)9 (4)4 (3)5(3)612
(5)5 (4)4 (4)13 (4)5 (3)4(3)712
(5)9 (5)6 (5)20 (7)13 (6)9(6)81
7 (6)12 (6)9 (6)16 (7)10(5)7(5)91
1(4)6 (4)3 (3)1 1(5)6 (4)3(3)1010
(5)7 (5)5 (4)12 (5)10 (5)8(5)
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present preliminary study is the first undertaken to test the
possible influence of the acute administration of sublingual
nitrates on the rest uptake of @Tc-teboroxime and, con
sequently, on its ability to differentiate between reversible
and fixed perfusion defects.
On the basis of our results, the slight superiority of rest
@Tc-teboroxime over early @Â°â€˜Tlredistribution imaging to
differentiate between reversible and fixed defects was con
firmed. On the other hand, after 201'flreinjection, a signif
icant decrease of the defect score was demonstrated both
compared to the 201'flredistribution and the @Â°@Tc-teborox
ime rest images. Furthermore, the 201'flreinjection images
were able to detect reversibility in a larger number of
segments than both @Â°@Tlredistribution and rest @Tc
teboroxime. The main result of this study, however, was
that in the rest @â€˜@Tc-teboroximeimages collected injecting
the tracer after the acute administration of ISDN, the up
take score was found to have improved in almost half of the
stress-induced defects. Accordingly, the total defect score
decreased significantly compared to both the @â€œ@Tc-te
boroxime rest and the 201'fl redistribution images, and it
was no longer statistically different from the 201'flreinjec
tion value. Furthermore, the final classification of fixed or
reversible segments in the @â€œ@Tc-teboroximeISDN scans
was the same as in 20111reinjection imaging. These data
support the initial hypothesis of the possible favorable role
of acute nitrate imaging in enhancing the recognition of
defect reversibility using @â€œTc-1abeledperfusion agents.
These data must however be evaluated with the utmost
caution owing to the several limitations of this preliminary
study. First, the patient population is extremely small.
Second, although they were all affected by prior infarction,
the patients were not studied because of symptoms or signs
of left ventricular dysfunction, but because of suspect ef
fort angina. Therefore, the indication for myocardial per
fusion imaging was not the possible detection of viable
hibernating myocardium. Actually, the majority of ternto
ries with uptake defects in the stress images were ischemic.
Accordingly, in most of these segments the tracer uptake
was found to be improved, albeit still abnormal, both in the
20111 redistribution and in the usual rest @â€œ@Tc-teboroxime
images. So, viability had already been demonstrated with
out the need for further scans. This implies that our results
must only be considered from the point of view of the
imaging technique and should not be analyzed in clinical
terms, since neither the 201'fl reinjection nor the ISDN
@Tc-teboroxime images influenced patient management
in this population. It must also be taken into account that
our results are based on the simple visual evaluation of the
tracer uptake and not on quantitative data. However, sim
ilar limitations are present in other reports about the issue
of defect reversibility and myocardial viability (16,24). Fi
nally, the possibilityof an apparentincreasein myocardial
activity, because of the partial volume effect due to the
improvement of either wall motion or thickening induced
by the ISDN, cannot be excluded (30). Nevertheless, from
a practical point ofview, this mechanism would also imply
FIGURE 2. Pkt of the defect score of the abnormal segments in
exerciseimagingandtheirchangesin redlstiibution(Redistr.)and
reinjectionimages @Â°ii,leftpenal)andintherestandISDNimages
(@â€˜Tc-teboroxime,right panel),respectively.The numberof seg
mentshavinga particularscore is writtenin the cirdes; the small
italic numberwrittenon each arrow shows how many segments
underwenta scorechangeindicatedby the arrowitself.
defects (17,19â€”23).Therefore, either late redistribution or
rest-reinjection images are needed to exclude the presence
of reversibility. Indeed, these have become widely used
methods for the detection of viable hibernating myocar
dium (17,19â€”23).The currently available @Tc-labeled
myocardial perfusion tracers require a separate injection at
rest for baseline imaging. This could theoretically enhance
their capability for demonstrating the reversibility of
stress-induced defects. Some reports suggested that rest
@Tc-teboroxime imaging is superior to early 201i@redis
tribution (6, 7). On the other hand, the few available data
demonstrate that rest 9@Tc-teboroxime imaging is less ef
fective than 201'flreinjection for the recognition of defect
reversibility (11 ). Similar data have been reported using
rest @Tc-sestamibi(24). Various approaches have been
proposed to overcome this limitation of @â€œ@Tc-label d
agents, including the simultaneous evaluation of left yen
tricular function to assess wall motion of the hypoperfused
territories (4). This is possible by the acquisition of first
pass radionuclide angiocardiography during tracer injec
tion (25,26). Alternatively, with @â€˜@Tc-sestaimbi,gated im
aging can be used (27). As regards @â€˜@â€˜Tc-teboroxime,the
analysis of myocardial washout has been suggested in or
der to differentiate between viable and non-viable tissue
(9,10).Anotherapproachisthatofperformingthetracer
rest injection under a stimulation that can improve, at least
transiently, the coronary blood flow in hypoperfused tern
tories. Recent data suggest that the acute administration of
nitrates may favorably affect coronary blood flow mainly,
but not exclusively, through the improvement of collateral
circulation (28,29). As far as perfusion imaging is con
cerned, various reports have shown that the acute admin
istration of nitrates increases uptake of 201'flor enhances
its redistribution, so that the detection of defect reversibil
ity is improved (12â€”16).Based on this information, the
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the presence of viable myocardium in the involved tern
tory.
CONCLUSION
The reinjection of @â€˜@Tc-teboroximeafter administration
of ISDN could improve the ability to differentiate between
reversible and fixed perfusion defects. This could be of
value in the detection of myocardial viability, although this
hypothesis cannot be demonstrated by the present study
because of patient selection criteria. Nevertheless, further
studies on wider populations, including patients with the
clinical suspicion of hibernating myocardium, are war
ranted.
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